ePaperEventsR.AGEmStarMajoritiStarPropertyStarCherishStarCarsifuStarSearchmyStarjobKualiKuntumSuriaFM988FM
LONDON (Reuters) -German software company SAP overtook Danish healthcare company Novo Nordisk as Europe's largest company by market capitalisation on Monday.
STOCKHOLM (Reuters) - Volvo Cars has signed an agreement to buy struggling Swedish battery maker Northvolt's stake in their joint battery venture NOVO Energy, the Sweden-based automaker said on Wednesday, without disclosing the price.
COPENHAGEN: Denmark’s economy has become intertwined with Novo Nordisk A/S, famous for its fast-selling weight-loss treatments.
Novo Nordisk A/S chief executive officer Lars Fruergaard Jorgensen will use a familiar argument to defend the US prices of blockbuster drugs Ozempic and Wegovy before a congressional committee led by Senator Bernie Sanders – it’s middlemen.
STOCKHOLM, June 18 (Xinhua) -- Fire broke out at a building of Danish pharmaceutical giant Novo Nordisk in Copenhagen, local media reported on Tuesday.
COPENHAGEN (Reuters) - There was no indication so far that three fires that broke out at Novo Nordisk's Danish facilities over the past month were connected or that they were caused by criminal activity, the company said on Wednesday.
DIABETES, a chronic ailment stemming from insufficient insulin—a hormone that regulates blood glucose levels— was once a serious life-threatening condition.
NOVO Nordisk’s decision to launch its weight-loss drug Wegovy in Britain last week despite severe supply constraints may partly have been motivated by a desire to get ahead of rival Eli Lilly’s own similar drug, industry sources say.
LONDON (Reuters) - Britain is reviewing a class of drugs used in a diabetes medicine and a weight-loss treatment sold by Novo Nordisk after some patients reported suicidal or self-harming thoughts, two weeks after similar action by the European Union.
PHILADELPHIA (Reuters) -Novo Nordisk on Saturday said the heart protective benefits of its wildly popular Wegovy obesity treatment are due to more than weight loss alone, according to new data presented at a major medical meeting on Saturday.
FRANKFURT (Reuters) - Supplies of Novo Nordisk's popular weight-loss drug Wegovy are limited in Germany less than a month after its launch in Europe's largest drug market, major drug distributors and doctors told Reuters.
(Reuters) -The European Medicines Agency said on Friday its committee has recommended expanding the use of Danish drugmaker Novo Nordisk's weight loss drug in adolescents aged 12 years and older.
Esco Lifesciences Group, a Singapore firm that pivoted from washing lab gowns to making high-tech equipment, raised $200 million from some of the world’s biggest health-care investors, paving the way for a possible listing in Hong Kong this year.
KLUANG: A man and a woman lost their lives in a tragic accident involving a car and four motorcycles on Jalan Kota Tinggi-Kluang early this morning.
LONDON (Reuters) - European companies that are spending big on generative artificial intelligence need to start showing returns on their massive outlays by next year, or risk investors losing patience after they paid sky-high prices to join the market boom.
Pharmaceutical giant Novo Nordisk is seeking as much as US$830 million (S$1.1 billion) in damages in an application to a Singapore court, saying that it was misled by a local biotech firm about the effectiveness of an experimental hypertension drug.
(Reuters) -A European Medicines Agency committee, on Thursday, accepted the use of an artificial intelligence (AI) tool called AIM-NASH in clinical trials to help identify the severity of a type of fatty liver disease.
In 'Kaki Lima: Pictures And A Story', Shih-Li Kow and Malek Hue unveil the tales of overlooked five-foot ways
SINGAPORE: Homebuyers snapped up some 1,150 new condominium units over the weekend with Lentor Central Residences claiming top spot and executive condo project Aurelle of Tampines following hot on its heels, while residential tower Aurea had a more muted showing.
WHEN Stephane Castel first met with a group of Maori people and other Pacific Islanders in New Zealand to discuss his biotech company’s plans for genetic research, the reception was cautious.
